POINT Biopharma Global Inc. Profile Avatar - Palmy Investing

POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand …

Biotechnology
US, Indianapolis [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of PNT's Analysis
CIK: 1811764 CUSIP: 730541109 ISIN: US7305411099 LEI: - UEI: -
Secondary Listings
PNT has no secondary listings inside our databases.